Montpellier University, EA2415, Institut Universitaire de recherche clinique, 34093, Montpellier Cedex 5, France.
Languedoc Mutualité, Nouvelles Technologies, AESIO, Montpellier, France.
Sci Rep. 2021 Sep 27;11(1):19104. doi: 10.1038/s41598-021-98604-6.
In France, more than 10 million women at "average" risk of breast cancer (BC), are included in the organized BC screening. Existing predictive models of BC risk are not adapted to the French population. Thus, we set up a new score in the French Hérault region and looked for subgroups at a graded level of risk in women at "average" risk. We recruited a retrospective cohort of women, aged 50 to 60, who underwent the organized BC screening, and included 2241 non-cancer women and 527 who developed a BC during a 12-year follow-up period (2006-2018). The risk factors identified were high breast density (ACR BI-RADS grading)(B vs A: HR = 1.41, 95%CI [1.05; 1.9], p = 0.023; C vs A: HR = 1.65 [1.2; 2.27], p = 0.02 ; D vs A: HR = 2.11 [1.25;3.58], p = 0.006), a history of maternal breast cancer (HR = 1.61 [1.24; 2.09], p < 0.001), and socioeconomic difficulties (HR 1.23 [1.09; 1.55], p = 0.003). While early menopause (HR = 0.36 [0.13; 0.99], p = 0.003) and an age at menarche after 12 years (HR = 0.77 [0.63; 0.95], p = 0.047) were protective factors. We identified 3 groups at risk: lower, average, and higher, respectively. A low threshold was characterized at 1.9% of 12-year risk and a high threshold at 4.5% 12-year risk. Mean 12-year risks in the 3 groups of risk were 1.37%, 2.68%, and 5.84%, respectively. Thus, 12% of women presented a level of risk different from the average risk group, corresponding to 600,000 women involved in the French organized BC screening, enabling to propose a new strategy to personalize the national BC screening. On one hand, for women at lower risk, we proposed to reduce the frequency of mammograms and on the other hand, for women at higher risk, we suggested intensifying surveillance.
在法国,有超过 1000 万名处于乳腺癌(BC)“平均”风险的女性被纳入了有组织的 BC 筛查中。现有的 BC 风险预测模型并不适用于法国人群。因此,我们在法国埃罗省建立了一个新的评分系统,并寻找处于“平均”风险的女性中不同风险级别的亚组。我们招募了一个回顾性队列的女性,年龄在 50 至 60 岁之间,她们接受了有组织的 BC 筛查,包括 2241 名非癌症女性和 527 名在 12 年随访期间(2006-2018 年)发展为 BC 的女性。确定的风险因素包括高乳腺密度(ACR BI-RADS 分级)(B 与 A:HR=1.41,95%CI [1.05;1.9],p=0.023;C 与 A:HR=1.65 [1.2;2.27],p=0.02;D 与 A:HR=2.11 [1.25;3.58],p=0.006)、母亲乳腺癌病史(HR=1.61 [1.24;2.09],p<0.001)和社会经济困难(HR 1.23 [1.09;1.55],p=0.003)。而早绝经(HR=0.36 [0.13;0.99],p=0.003)和初潮年龄在 12 年后(HR=0.77 [0.63;0.95],p=0.047)是保护因素。我们确定了 3 个风险组:低、中、高,分别为。低风险阈值为 12 年风险的 1.9%,高风险阈值为 12 年风险的 4.5%。3 个风险组的平均 12 年风险分别为 1.37%、2.68%和 5.84%。因此,12%的女性的风险水平与平均风险组不同,涉及到法国有组织的 BC 筛查的 60 万名女性,可以提出一种新的策略来个性化国家 BC 筛查。一方面,对于低风险的女性,我们建议减少乳房 X 光检查的频率,另一方面,对于高风险的女性,我们建议加强监测。